Upon baicalin pre-treatment, LPS induced BV-2 microglia expression of NO, iNOS, IL-1, PGE2, ROS, IL-6, TNF-, COX-2 decreased and TLR4/NF-B pathway activation was reduced (Yan et al., 2020
Patients who were prescribed semaglutide or liraglutide for at least one year were slightly more likely to maintain or continue to lose weight in the year following treatment
The safest approach is individualized care guided by a licensed medical provider familiar with both wellness therapies and overall patient health. For patients exploring recovery-focused wellness support, the safest approach is working with a licensed provider familiar with both peptide wellness therapies and GLP-1-based medical weight loss care
Nader E, Romana M, Guillot N, Fort R, Stauffer E, Lemonne N, et al
J Physiol 577:5919, PMID: 17008380 Lehre KP, Levy LM, Ottersen OP, Storm-Mathisen J, Danbolt NC (1995) Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations
Nausea associated with GLP-1 receptor agonists typically occurs because these medications delay the rate at which food leaves the stomach (gastric emptying)